Evidence map›Paper›PMID 29942183›Full record

ReviewSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society

Low vision rehabilitation: An update.

Mark E Wilkinson, Khadija S Shahid

Registry-linked trialAbstract readReview
In one paragraph

Review in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04736264 (Malay Glaucoma Eye Study II), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04736264 naunknown statusnot on this map

Malay Glaucoma Eye Study II: Elucidating Navigation, Mobility and Reading Ability to Improve Quality of Life and Progression of Primary Glaucoma

TypeinterventionalSponsorUniversiti Sains MalaysiaRan2020 to 2024Enrolled300ConditionsPrimary Open Angle Glaucoma, Primary Angle Closure GlaucomaArmsVisual rehabilitation module: navigation and mobility, Visual rehabilitation module: exercise, Visual rehabilitation module: reading
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Low vision rehabilitation: An update.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark E WilkinsonUniversity of Iowa Carver College of Medicine, Department of Ophthalmology & Visual Sciences, Director, Vision Rehabilitation Services, Wynn Institute of Vision Research, 200 Hawkins Drive, Iowa City, IA 52242, United States.
Khadija S ShahidUniversity of Iowa Carver College of Medicine, Department of Ophthalmology & Visual Sciences, 201 Hawkins Drive, Iowa City, IA 52242, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article provides information concerning issues related to the care of individuals who are visually impaired. Issues reviewed include determining who should be referred for vision rehabilitation services, Charles Bonnet syndrome, visual acuity, contrast sensitivity and visual field testing along with Useful Field of View testing. This article also discusses technology advances that can enhance the visual functioning of individuals who are visually impaired, including how these advances can help drivers with visual impairments to continue to safely operate motor vehicles, at least on a limited basis. Finally, resources that are available to both encourage and motivate patients to take advantages of vision rehabilitation services are reviewed.

Indexed as

Charles bonnet syndromeLow vision rehabilitationUseful field of viewVisual impairment

Identifiers

PMID29942183
PMCPMC6010602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.